Traditional biologics, new biotherapeutics formats and biosimilars are flooding development pipelines. Thus, analytical function is rapidly evolving, demanding high-throughput and high-resolution tools, focused biomolecular and biophysical assays, rapid analytical and impurity profiling strategies and cutting-edge data analytics. Together, the four conferences part of Pipeline 5: Analytics & Impurities feature in-depth perspectives on the most critical steps in characterization of biologics, stability issues arising from particles, impurities and extractables and leachables and effective data analysis and interpretation.
Characterization of Biotherapeutics
Detection and Characterization of Particulates and Impurities
Extractables and Leachables